Perioperative Clinical Usage of Phellinus Linteus as a Nutraceutical for Non-FOLFIRINOX-Based Postoperative Adjuvant Chemotherapy for Resected Pancreatic Cancer: A Retrospective Cohort Study

Perioperative Clinical Usage of Phellinus Linteus as a Nutraceutical for Non-FOLFIRINOX-Based Postoperative Adjuvant Chemotherapy for Resected Pancreatic Cancer: A Retrospective Cohort Study

Introduction: Most patients with pancreatic cancer experience systemic recurrence within 1 to 2 years after radical pancreatectomy. Phellinus linteus (PL) has demonstrated anti-inflammatory, antioxidant, and anti-cancer properties, suggesting potential as an adjunct to cancer therapy. This study aim...

Full description

Saved in:
Bibliographic Details
Main Authors: Juwan Kim MD, Seung Soo Hong MD, Sung Hyun Kim MD, MS, Ho Kyoung Hwang MD, PhD, Chang Moo Kang MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354251353499
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items